Drugs / JNJ-88545223
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07321873 | Jan 2026 → Jun 2027 expected | psoriatic arthritis | Janssen Research & Development, LLC | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JNJ-88545223 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07321873 ↗ |